Just as the previous decade has witnessed the maturity of percutaneous and surgical therapies for coronary artery disease, the next decade is likely to witness a tremendous change in our approach to therapy for heart valve disease. Already, we have seen a remarkable growth of percutaneously implanted heart valves in Europe and a number of novel devices being developed for repair or replacement ...